Pehlivan, U.A.; Somay, E.; Yilmaz, B.; Besen, A.A.; Mertsoylu, H.; Selek, U.; Topkan, E.
Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy. J. Clin. Med. 2023, 12, 6863.
https://doi.org/10.3390/jcm12216863
AMA Style
Pehlivan UA, Somay E, Yilmaz B, Besen AA, Mertsoylu H, Selek U, Topkan E.
Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy. Journal of Clinical Medicine. 2023; 12(21):6863.
https://doi.org/10.3390/jcm12216863
Chicago/Turabian Style
Pehlivan, Umur Anil, Efsun Somay, Busra Yilmaz, Ali Ayberk Besen, Huseyin Mertsoylu, Ugur Selek, and Erkan Topkan.
2023. "Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy" Journal of Clinical Medicine 12, no. 21: 6863.
https://doi.org/10.3390/jcm12216863
APA Style
Pehlivan, U. A., Somay, E., Yilmaz, B., Besen, A. A., Mertsoylu, H., Selek, U., & Topkan, E.
(2023). Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy. Journal of Clinical Medicine, 12(21), 6863.
https://doi.org/10.3390/jcm12216863
